Skip to Content

Meningococcal Conjugate Vaccine Dosage

Medically reviewed by Last updated on March 13, 2020.

Usual Adult Dose for Meningococcal Meningitis Prophylaxis

0.5 mL intramuscularly once

Usual Pediatric Dose for Meningococcal Meningitis Prophylaxis

2 years or older:
0.5 mL intramuscularly once.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dose Adjustments

-Booster doses of 0.5 mL, subcutaneously, may be given to patients at high risk for meningococcal disease.
-The ACIP (Advisory Committee on Immunization Practices) has revaccination recommendations.


-Severe allergic reaction (e.g. anaphylaxis) to any of the ingredients or to other CRM197-, diphtheria toxoid-, or meningococcal-containing vaccine

Safety and efficacy have not been established in patients younger than 2 years.
To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS) at:

Consult WARNINGS section for additional precautions.


Data not available

Other Comments

Administration advice:
-The deltoid is the preferred site.
-Do not administer IV or IM.

Storage requirements:
-Refrigerate; do not freeze.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.